3.63
Lantern Pharma Inc 주식(LTRN)의 최신 뉴스
Will Lantern Pharma Inc. stock recover after recent dropTrade Risk Summary & Technical Pattern Alert System - newser.com
Can Lantern Pharma Inc. stock deliver consistent earnings growthJuly 2025 Macro Moves & Weekly High Return Opportunities - newser.com
How Lantern Pharma Inc. stock reacts to oil pricesTrade Volume Summary & Risk Controlled Stock Pick Alerts - newser.com
How to interpret RSI for Lantern Pharma Inc. stockMarket Trend Summary & Fast Gain Swing Alerts - newser.com
Why Lantern Pharma Inc. stock is favored by pension fundsGap Up & High Accuracy Investment Entry Signals - newser.com
Will Lantern Pharma Inc. stock maintain dividend yieldQuarterly Trade Review & Breakout Confirmation Trade Signals - newser.com
Lantern Pharma : Corporate Overview - MarketScreener
How Lantern Pharma Inc. stock performs in weak economyQuarterly Profit Review & Low Risk High Win Rate Stock Picks - newser.com
Is Lantern Pharma Inc. stock a buy before product launchesCEO Change & Accurate Intraday Trade Tips - newser.com
When is the best time to exit Lantern Pharma Inc.2025 Market Trends & Technical Confirmation Trade Alerts - newser.com
What drives Lantern Pharma Inc stock priceEvening Star Patterns & Big Gains Small Budget - earlytimes.in
Is Lantern Pharma Inc. stock attractive for income investorsQuarterly Profit Summary & Short-Term Trading Alerts - newser.com
Using economic indicators to assess Lantern Pharma Inc. potentialJuly 2025 Institutional & Safe Investment Capital Preservation Plans - newser.com
Enlivex Therapeutics and Lantern Pharma Interviews to Air on the RedChip Small Stocks, Big Money(TM) Show on Bloomberg TV - Pocono Record
Full technical analysis of Lantern Pharma Inc. stock2025 Valuation Update & Weekly Breakout Watchlists - newser.com
Lantern Pharma Inc. stock trendline breakdownTrade Volume Summary & Advanced Technical Analysis Signals - newser.com
Lantern Pharma to Present AI-Driven Cancer Drug Development & Research Platforms at Inaugural AI for Biology and Medicine Symposium at UNT - MarketScreener
Emerging Biotech Stars Poised for Multi-Billion-Dollar Breakthroughs (MDCX, ACTU, LTRN, TNXP) - MarketScreener
Lantern Pharma Presents LP-284 Clinical Data at 25th LL&M Congress, Highlighting Complete Response in Therapeutically Exhausted DLBCL Patient & Therapeutic Potential in Advanced B-Cell Cancers. - BioSpace
Lantern Pharma (NASDAQ: LTRN) Reports Complete Metabolic Response in Phase 1 LP-284 Trial at LL&M Congress - Digital Journal
Lantern Pharma (LTRN) Reports Promising Phase 1 Trial Results fo - GuruFocus
Lantern Pharma presents LP-284 clinical data at 25th LL&M Congress - MarketScreener
What technical signals suggest for Lantern Pharma Inc. stockGDP Growth & Growth Focused Stock Pick Reports - fcp.pa.gov.br
자본화:
|
볼륨(24시간):